Ibumol

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ibumol

What is Ibumol? A Foundational Overview

Property Description
Active ingredient Acetaminophen and Ibuprofen
Form Oral Solid (Tablet/Caplet)
Pharmacological class Analgesic, Antipyretic, and NSAID Combination
Common use Relief of mild-to-moderate pain and fever
Origin Synthetic Compound

What Type of Medicine is Ibumol and What is its Classification?

Ibumol is a Fixed-dose combination product classified as an Analgesic (pain reliever) and Antipyretic (fever reducer). This proprietary medicine is typically available as an Oral solid dosage form, such as a tablet or caplet. The formulation, composed of entirely Synthetic compounds, belongs to the pharmacological class of analgesic and Nonsteroidal Anti-inflammatory Drug (NSAID) combinations. This dual classification is clinically recognized for providing relief across different pain types, distinguishing it from single-agent analgesics.

What Active Ingredients Does Ibumol Contain?

Ibumol contains two core Active ingredients: Acetaminophen (Paracetamol) and Ibuprofen. The integration of these two established agents is the defining feature of the medication. Fixed-dose combinations of these ingredients are utilized for treating acute pain. This pairing helps manage pain by utilizing two different mechanisms in a single dose. Acetaminophen primarily provides central pain relief and fever reduction, while Ibuprofen contributes both pain relief and a significant Anti-inflammatory effect as an NSAID.

What is the General Purpose of Ibumol?

The general purpose of the Acetaminophen/Ibuprofen combination is the effective symptomatic management of common discomforts, such as headaches or muscle aches. It is primarily used to relieve mild to moderate pain and reduce elevated body temperature (fever). By utilizing a synergistic formulation—one component acting centrally on pain signals and the other addressing inflammation peripherally—the medicine offers a robust approach for initial, general management of these common symptoms.

What side effects are possible with Ibumol?

Possible Side Effects and Safety Information

This section describes the officially documented adverse reactions and safety characteristics of the acetaminophen and ibuprofen combination, as classified by government regulatory authorities.

Adverse Reactions by Classification

Side effects are grouped by the physiological system they affect, aligning with System-Organ Classifications (SOC) used in regulatory documents. Based on clinical data, effects classified as Common typically include non-serious events such as nausea, vomiting, headache, and dizziness.

Documented Serious Adverse Reactions

The most critical safety concerns are categorized as Serious Adverse Reactions, which require explicit documentation due to their clinical significance. The acetaminophen component is associated with a risk of severe hepatotoxicity, which can lead to acute liver failure. The ibuprofen (NSAID) component is associated with risks of serious cardiovascular thrombotic events, including myocardial infarction and stroke, as well as severe gastrointestinal adverse events, such as bleeding, ulceration, and perforation.

Rare but severe skin reactions (such as SJS and TEN) and anaphylactic reactions are also officially documented.

Safety Restrictions and Contextual Patterns

The risk of cardiovascular events may increase with the duration of use, and serious gastrointestinal events can occur without warning symptoms at any time. The medication is contraindicated in patients with a history of allergic-type reactions to NSAIDs or aspirin, and in patients who have undergone CABG surgery.

Specific safety considerations apply to certain populations: Older adults have a greater risk for serious gastrointestinal events. Use in individuals with severe hepatic or renal impairment is restricted. Safety and efficacy are not established for children younger than 12 years of age.

Overdose and Emergency Response

The official regulatory documentation mandates that in the event of an overdose or suspected overdose with Ibumol, individuals must seek immediate medical attention or contact a Poison Control Center right away. This action is required even if the patient feels well, due to the critical risk of time-delayed, severe hepatic toxicity originating from the Acetaminophen component. Documented early manifestations may include nausea, vomiting, abdominal pain, and pallor. Severe, life-threatening outcomes officially documented include acute liver failure, acute renal failure, and serious events affecting the cardiovascular and nervous systems, such as stroke, myocardial infarction, or convulsions. N-acetylcysteine (NAC) is the specific antidote for Acetaminophen poisoning; however, no specific antidote is known for the Ibuprofen component, which necessitates symptomatic and supportive treatment. Hospital monitoring and continuous monitoring of vital signs are required. Increased risk of severe hepatic injury is officially noted for individuals with underlying liver disease, chronic malnutrition, or those with concurrent alcohol ingestion. This prompt response is critical for adults as well as for children.

Therapeutic Uses of Ibumol

What Ibumol Treats: Main Uses and Benefits

Ibumol is a combination medicine used in situations involving certain distressing symptoms. It is commonly applied in acute episodes where symptoms create noticeable interference with daily stability. The medication may be relevant in clinical settings marked by heightened patient distress, and is applied across domains where additional symptomatic support is needed.

Ibumol is generally relevant for easing symptoms related to mild-to-moderate physical discomfort and elevated body temperature. The combination is indicated for the temporary relief of specific symptomatic discomforts, and is applicable within clinical settings that involve acute symptom patterns.

It is commonly used across conditions presenting with acute episodes, including the symptomatic management of tension headaches, muscle aches, dental discomfort, menstrual cramps (dysmenorrhea), and the aches and fever associated with the common cold or flu. The medication is relevant for easing symptoms related to inflammatory or irritative states, and may assist with maintaining functional stability during difficult episodes.


Quick Fact: Relief for Combined Symptoms

The formulation is applied when symptoms cluster, particularly the dual presence of pain and inflammation, or when systemic aches accompany fever, which supports general well-being during symptomatic phases.

Eligibility and Restrictions for Use

Ibumol's use is officially established for adults and adolescents 12 years of age and older according to regulatory documentation. The product label defines specific populations who are contraindicated and must not use the medicine. These absolute prohibitions include individuals with a known hypersensitivity to Acetaminophen, Ibuprofen, other NSAIDs, or excipients.

Use is also strictly prohibited in the setting of Coronary Artery Bypass Graft (CABG) surgery and for patients diagnosed with severe hepatic impairment or severe active liver disease. Eligibility is further restricted as safety and efficacy have not been established for children younger than 12 years of age. Use is limited or avoided in pregnancy, particularly from 20 weeks onward, due to documented fetal risk.

Conditional use, often requiring caution, applies to patients with a history of severe heart failure, kidney disease, or stomach ulcers/bleeding. Older adults may also require caution due to an increased susceptibility to age-related gastrointestinal issues.

What should I know about interactions with other medicines?

Interaction Map: Interactions with other medicines and products — official regulatory information for Ibumol

Interaction Scope

  • Medicinal product categories with documented interactions: Other Analgesics (NSAIDs and Acetaminophen), Anticoagulants, Antiplatelet agents, Corticosteroids, Diuretics, ACE inhibitors, Angiotensin II Receptor Blockers (ARBs), and Lithium.
  • Specific interacting medicines (if explicitly listed): Warfarin, low-dose Aspirin (for antiplatelet effects).
  • Mechanistic basis of interactions (only if stated in label): Additive organ toxicity, Additive pharmacodynamic risk (increased bleeding risk), Reduced efficacy (decreased antihypertensive effect), and Reduced clearance (increased serum concentration of Lithium).
  • Interaction-related restrictions: Strictly contraindicated with other products containing Acetaminophen or any other NSAID, and for use in the peri-operative setting of Coronary Artery Bypass Graft (CABG) surgery. Restriction on concurrent use with three or more alcoholic drinks per day.
  • Population-specific interaction notes (if applicable): The risk of serious stomach bleeding is documented as higher in the elderly population (age 60 or older). The risk of liver damage is noted as heightened in patients with existing liver disease.

Resulting Interaction Structure

Official regulatory documents establish that the product's interaction profile is defined primarily by the combined risks of its two active ingredients. This includes the absolute prohibition against using other analgesics due to the risk of additive organ toxicity, and the pharmacodynamic and exposure-altering effects of the NSAID component on cardiovascular and renal medications. This defined structure mandates specific constraints for co-administration with other drug categories and substances, particularly those affecting the gastrointestinal tract, blood coagulation, and fluid balance, according to the official label.

Mechanism of Action

️ How Ibumol Works: Mechanism of Action

Dual-System Regulation via COX Inhibition

This combination engages the Arachidonic Acid Cascade by targeting the Cyclooxygenase ( COX) enzymes that synthesize prostaglandins. Ibuprofen non-selectively inhibits peripheral COX-1 and COX-2, which reduces the production of inflammatory mediators in peripheral tissues. Simultaneously, Acetaminophen modulates central COX activity, initiating a cascade that leads to the adjustment of the hypothalamic temperature set point. This results in the modification of the biological response to inflammatory mediators and the alteration of central thermoregulation.


Complementary Central Nervous System (CNS) Pathway Modulation

The second, unique mechanistic domain involves the central action of Acetaminophen on specific CNS pathways. Its active metabolite interacts with TRPV1 receptors and can modulate components of the Endocannabinoid System in the spinal cord and brain. This mechanism directly impacts the processing of nociceptive signals, leading to the central alteration of signal perception and transmission. This central effect acts in conjunction with the peripheral action of Ibuprofen, resulting in the simultaneous modification of peripheral and central signaling processes.

Dosage and Administration Information

How to Use Ibumol: Official Administration Guidelines

Ibumol, a fixed-dose combination of acetaminophen and ibuprofen, is strictly approved for oral administration as a single oral solid dosage form (tablet or caplet). The official protocol dictates precise rules concerning dosing quantity, timing, and duration.


Administration Scope and Limits

Parameter Official Instruction (Adults)
Dosing Schedule Take 1 or 2 units (tablets/caplets) for symptom relief.
Frequency Doses must be separated by a minimum interval of 4 hours, taken every 4 to 6 hours as required.
Maximum Daily Limit A strict maximum of 6 units (3000 mg acetaminophen / 1200 mg ibuprofen) is allowed in any 24-hour period.

Special Procedural Conditions

Tablets or caplets must be swallowed whole with water. Following typical usage principles for the ibuprofen component, the medicine may be taken with food or milk if gastric discomfort is a concern.

Use is subject to official duration limits: the course should not exceed 10 days for pain or 3 days for fever. For older adults, guidance advises initiating treatment with the lowest effective dose. This overall protocol establishes a precise, self-limiting administration pattern that enforces strict boundaries on both the quantity and duration of use.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ibumol

The research on Ibumol, a fixed-dose combination of acetaminophen and ibuprofen, is mainly drawn from randomized controlled trials (RCTs) and systematic reviews that meet the standards of major health organizations. These studies primarily focuses on examining responses over defined time intervals. The information below summarizes what is known about the structure and findings of this research base, without offering any clinical advice.


Evidence for Use in Acute Postoperative Pain

Research has primarily focused on the combination as the study treatment for patients experiencing acute, predictable physical discomfort, such as after minor surgical procedures like dental extractions. Studies typically involve short-term, controlled trials. Researchers monitored outcomes related to physical discomfort, including time to a measured difference in pain intensity and the level of discomfort measured over a few hours.

The evidence is heavily concentrated on the dental pain model, which means the results apply only to the populations studied and may provide limited insight into other less defined types of acute pain. Follow-up durations were limited, focusing only on the immediate effects, and long-term effects are not fully established for continuous use.


Evidence for General Acute Pain and Symptom Management

The combination was the study treatment in research exploring conditions associated with acute or disruptive episodes, such as musculoskeletal aches and menstrual cramps (dysmenorrhea). These trials involved patients with symptoms that may vary in intensity. Studies explored outcomes related to functional imbalance and the reduction in reported pain intensity over several hours or days.

However, the evidence quality varies across studies due to the wide range of pain conditions and measurement tools used. Sample sizes were modest in some analyses, and comparative evidence is lacking for many common single-agent pain relievers. This means the research provides insight into short-term changes, but the findings can be mixed.

Key Studies & References

  1. Efficacy and safety of ibuprofen and acetaminophen in children and adults: a meta-analysis and qualitative review (NCBI/AHRQ)
  2. PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION COMBOGESIC® Acetaminophen and Ibuprofen Tablets (Regulatory Document)

Frequently Asked Questions (FAQ)

Common questions about Ibumol (FAQ)


Q: Can Ibumol be used for types of chronic pain?

Official drug labels indicate that this product is for the temporary relief of minor aches and pains. Regulatory documents recommend limiting the maximum duration of use (e.g., typically not more than 10 days for pain). Use beyond this defined time is outside the scope of the non-prescription regulatory guidance and requires physician assessment.


Q: How is Ibumol different from other common over-the-counter pain relievers?

This product is a fixed-dose combination that includes two distinct active ingredients: acetaminophen and ibuprofen. This formulation combines two different mechanisms of action—central pain relief and anti-inflammatory action. This dual composition distinguishes the product from pain relievers that contain only a single active ingredient.


Q: Are there specific signs that could indicate a serious side effect from Ibumol?

Official warnings describe specific patient signs that warrant attention. These include symptoms of liver damage, such as yellowing of the skin or eyes and non-stopping nausea or vomiting. Signs of a serious allergic reaction, like hives, facial swelling, or trouble breathing, are also listed. If signs of internal bleeding, such as black or tarry stools, are noticed, regulatory warnings recommend seeking emergency medical attention.


Q: Is there a link between long-term use of Ibumol and potential health risks?

Regulatory documents explicitly warn that using the product for a longer time than directed, or using higher doses, increases the risk of serious side effects. These risks are described to include serious cardiovascular events, such as myocardial infarction and stroke, as documented in official warnings, as well as severe gastrointestinal bleeding.


Q: Can taking Ibumol cause or contribute to high blood pressure?

Official information indicates that the product’s label requires caution for patients with a pre-existing history of high blood pressure. The ibuprofen component, which belongs to the class of NSAIDs (Nonsteroidal Anti-inflammatory Drugs), has been associated with the potential for new onset or worsening of existing high blood pressure.


Q: How quickly does Ibumol typically start working to relieve symptoms?

Regulatory reviews of the combination product have supported that its effect in relieving minor aches and pains can last for the duration of the recommended dosing interval, typically up to eight hours.


Q: What is the expected duration of Ibumol's effects once a dose is taken?

According to official dosing and administration instructions, the recommended dosing is typically separated by eight hours. Clinical data reviewed by regulatory authorities supported pain relief lasting for this eight-hour duration.


Q: Is Ibumol generally described as being safe to take right before bedtime?

Drowsiness and dizziness are listed as common side effects of this medicine. Official warnings note the potential for these effects, which is a consideration for use during times that require alertness, such as before bedtime or driving.


Q: Is Ibumol considered a drug that requires a prescription in some regions?

This specific combination product is available in different dosage strengths and forms across various regions. Some formulations are sold over-the-counter, while other higher-strength or specific doses require a prescription for short-term acute pain management.


Q: Is Ibumol described in official documents as being a narcotic or addictive?

The product is classified as a combination analgesic (pain reliever) and Nonsteroidal Anti-inflammatory Drug (NSAID). Official documentation confirms that it is not an opioid and does not become habit-forming.


Q: Does Ibumol cause drowsiness or affect driving ability?

Dizziness and drowsiness are listed in official documents as common side effects of this medicine. Patients are advised that these effects may affect their ability to drive or operate heavy machinery.


Q: What is the procedure mentioned in official labels if a scheduled dose of Ibumol is missed?

Regulatory guidance describes a procedure where a missed dose is taken as soon as it is remembered. However, it advises against taking the dose if it is almost time for the next scheduled dose. The guidance also emphasizes that a double dose should not be taken to compensate for a forgotten dose.


Q: Does the time of day matter when taking Ibumol?

Regulatory instructions prioritize adherence to the recommended dosing interval (e.g., every 8 hours) and the maximum daily dose. The medication can be taken as needed for symptoms, provided the dose spacing is maintained and the maximum daily limit is not exceeded.


Q: Does Ibumol contain common allergens like gluten, dairy, or lactose?

Official drug labels list the inactive ingredients for each product, which may vary by manufacturer. The inactive ingredients list on the packaging for the specific product is the official source of information for patients concerned about specific allergens.


Q: What is the official first aid advice for someone who has accidentally taken too much Ibumol?

Official warnings state that emergency medical attention is required right away if an overdose is suspected, even in the absence of immediate symptoms. This is due to the potential for delayed severe liver damage associated with the acetaminophen component.


Q: Where can a user find the official package insert or summary of product characteristics (SmPC) for Ibumol?

Official drug labels, such as Package Inserts or Summaries of Product Characteristics, are available for public access. These are typically hosted on government-run websites, such as the US National Institutes of Health (NIH) DailyMed service.

How should Ibumol be stored and disposed of?

Storage and Disposal Instructions for Ibumol

Storage of Ibumol (Acetaminophen/Ibuprofen combination) must follow official regulatory requirements to ensure product integrity and safety.


Required Storage Conditions

  • Temperature: Store at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). Avoid excessive heat above 40 C.
  • Protection: The medicine must be stored in a dry place and protected from light by keeping it in its original packaging.
  • Safety: Keep this medicine out of the sight and reach of children.

Official Disposal Rules

Unused or expired Ibumol must be disposed of in accordance with local requirements. The product should not be flushed down a sink or toilet. The preferred method is a drug take-back program. If unavailable, the FDA recommends mixing the medicine with an undesirable substance, sealing it in a container, and discarding it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ibumol found in:

A-Z Index: